Pill Identifier App

Could your pain be related to Rheumatoid Arthritis?

Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.

Learn More

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Get Started

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Welcome to Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Featured Topic Centers

Daily Medical News


Is 'Untreatable' Gonorrhea On the Way?

TUESDAY, Jan. 8 -- The sexually transmitted disease gonorrhea is becoming increasingly resistant to available antibiotics, including the last oral antibiotic used to treat the bacterium, new Canadian research shows. In a study of nearly 300 people infected with Neisseria gonorrhoeae, the researchers found a treatment failure rate of nearly 7 percent in people treated with cefixime, the last...

How Much Caffeine in That Supplement? Hard to Tell

TUESDAY, Jan. 8 -- A new study finds that popular supplement pills and powders found for sale at many military bases, including those that claim to boost energy and control weight, often fail to properly describe their caffeine levels. Some of these products -- also sold at health-food stores across the county -- didn't provide any information about caffeine on their labels despite being packed...

Vitamin D Doesn't Improve Knee Arthritis, Study Finds

TUESDAY, Jan. 8 -- Taking vitamin D supplements does not reduce pain or cartilage loss in people with knee osteoarthritis, researchers have found. Some prior studies had suggested that vitamin D might benefit these patients. "Vitamin D is a very hot topic in medicine and many people in the United States have low vitamin D levels," noted one expert not connected to the study, Dr. Diane Horowitz,...


Latest Pharma Industry News


Many Doctors Prescribe Costlier Drugs Than Needed, Study Finds

Many Doctors Prescribe Costlier Drugs Than Needed, Study Finds [Milwaukee Journal Sentinel] From Milwaukee Journal Sentinel (WI) (January 8, 2013) Jan. 08--More than a third of doctors said they prescribe brand name drugs simply because patients ask for them even when cheaper generics would be appropriate, according to a new study. The practice, which can contribute to higher health care...

Death Rates for Most Major Cancers Decline Slightly

Death Rates for Most Major Cancers Decline Slightly [the Pittsburgh Tribune-Review] From Pittsburgh Tribune-Review (PA) (January 8, 2013) Jan. 07--Top researchers on Monday reported a slight decline in overall cancer death rates nationwide over a 10-year period but an increase in the incidence of some cancers, prompting a renewed call for prevention efforts. Cancer death rates declined for...

FDA approves Kineret for the treatment of NOMID

Sobi (STO: SOBI) today announced that the US Food and Drug Administration (FDA) has approved Kineret® (anakinra) for the treatment of children and adults with neonatal-onset multisystem inflammatory disease (NOMID). Kineret is the first and only FDA-approved therapy for NOMID, the most severe form of cryopyrin associated periodic syndromes (CAPS). This is the first approval allowing the...


Latest Additions to Drugs.com

Recently added consumer and prescribing information: Fulyzaq, Sirturo, Eliquis, Juxtapid, Adasuve, Raxibacumab, Raxibacumab, Gattex, Signifor, Iclusig ...also see new filings.

Transparency in Clinical Trials: A New Paradigm Shift?

The British Medical Journal (BMJ), a leading, peer-reviewed medical journal, has announced that beginning in January 2013 it will require all authors of drug or device clinical trials who publish in BMJ – whether industry-funded or not – to provide detailed scientific study data to anyone with a reasonable request. Although the policy specifics are ...

Q3 2012 Drug Sales Data Released: Nexium and Abilify Remain the Leading Brands

The latest U.S. drug sales data has been released by Drugs.com. As in the previous quarter, proton-pump inhibitors, antipsychotics and statins remain in the top-selling therapeutic categories. Merck’s asthma and allergy preventive Singulair predictably drops out of the top five drugs due to Q3 patent loss. AstraZeneca’s Nexium, not forecast to lose patent protection until May 2014, ...

Bristol-Myers Squibb Acquisition Results in $1.8 Billion Loss

Bristol-Myers Squibb (BMS) has announced that they will discontinue all development of their chronic hepatitis C (HCV) treatment BMS-986094, a nucleotide polymerase (NS5B) inhibitor previously in Phase 2 clinical trials. BMS reports that nine study patients were hospitalized with heart and kidney toxicity, with one patient death due to heart failure. The exact cause of ...

See more blog posts or follow us on twitter.